All Type of News
JW Pharmaceutical’s ‘Emicizumab’ designated as orphan drug treating hemophilia A
‘Emicizumab,’ a hemophilia A treatment which has been widely known to become a global new drug, has also raised attention of patients as being designated as an orphan drug even in Korea.
JW Pharmaceutical announced o...
MFDS to consider development of medicinal drugs containing marijuana
A plan will be carried out to extend the range of treatment options for rare, incurable disease patients and to approve development of medicines containing marijuana.
The Ministry of Food and Drug Safety(MFDS) announ...
Medicine fees for KRW 16.2 trillion, accounting for total National Health Insurance Service benefits last year
According to the ‘National Insurance Service Statistics’ and ‘Medical Fee Statistics Index’ that the National Health Insurance Service(Chairman Yong-Ik Kim, NHIS) and the Health Insurance Review and Assessment Service...
Awkward situation for MOHW with emergency household medicine list, “We’ll still wait”
As the Korean Pharmaceutical Association’s(KPA) general meeting is postponed to April, the Ministry of Health and Welfare have also had an awkward and difficult time.
The MOHW and the deliberative committee were supp...
Active generic market with increase of product with PMS or patent expiring
The number of medicinal drugs tested bioequivalently this year was 226 products, increased by 73% compared to the same time period of the last year.
This means Korean pharmaceutical companies have been active in deve...
Samsung Bioepis records KRW 314.8 billion sales and continue losses in operating & net profits
Samsung Bioepis(unlisted, subsidiary of Samsung Biologics) achieved KRW 314.8 billion sales last year based on the audit report on March and grew 113.4% up compared to the year before.
The company continued to make n...
MFDS creates ‘General Information System’ to look all the information about medicines at glance
The Ministry of Food and Drug Safety(MFDS) announced on the 21st that it would create the ‘General Medicine Information System’ to check all the information at a glance about data from clinical trials, approval, distr...
ACRC punishes pharmas providing expedient, illegal rebates through CSOs
The government will interrupt pharmaceutical companies to expediently provide illegal rebates through a third party like CSOs(contract sales organizations) by giving part of commissions to hospitals.
It will be diffi...
Listed pharmas taking 101 days to turn over receivables after selling medicines
Listed pharmaceutical companies reportedly took about 101 days on average to return money they spent from selling medicinal drugs.
Yakup Shinmoon(www.yakup.com) analyzed the KOSPI and KOSDAQ listed pharmaceutical com...
How long KPBMA will leave Chairman position empty?
The Chairman position of the Korea Pharmaceutical and Bio-Pharma Manufacturers Association is expected to continue absence by the 2nd quarter of the year.
The Korea Pharmaceutical and Bio-Pharma Manufacturers Associa...
